COVID-19 Vaccine

Most severe acute respiratory syndrome coronavirus (SARS-CoV-2) mutations cause only mild harm. However, a small percentage of mutations can boost viral virulence and promote host-virus interactions that are critical to viral entry and infection. For example, SARS-CoV-2 spike protein mutations can significantly affect viral behavior, as the spike protein mediates viral attachment to host cell
0 Comments
A monoclonal antibody Covid treatment from Vir Biotechnology and GlaxoSmithKline “stands up well” to all variants of the virus, Vir President and CEO George Scangos told CNBC’s “Power Lunch” on Wednesday. Scangos’ comments came after the two companies announced contracts to sell $1 billion worth of their antibody, sotrovimab, to the U.S. government. The Food
0 Comments
With a COVID-19 vaccine authorized by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention for children ages 5 and up, families may be planning long awaited holiday travel. For people traveling with kids, it is still important to follow safety precautions to protect your family from the coronavirus
0 Comments
The coronavirus disease 2019 (COVID-19) pandemic, caused by the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alerted the world to the seriousness of the threat posed by novel viruses. To protect the world’s population from similar future outbreaks, broadly protective vaccines against SARS-related coronaviruses are urgently needed. In a recent study published in Journal
0 Comments
Maryland National Guard Specialist James Truong (L) administers a Moderna coronavirus vaccine at CASA de Maryland’s Wheaton Welcome Center on May 21, 2021 in Wheaton, Maryland. Chip Somodevilla | Getty Images Food and Drug Administration scientists on Tuesday declined to take a stance on whether to back booster shots of Moderna’s Covid-19 vaccine, saying data
0 Comments
In this article PFE Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on October 01, 2021 in San Rafael, California. Justin Sullivan | Getty Images The effectiveness of Pfizer and BioNTech‘s Covid-19 vaccine against infection tumbles over several months, falling from a peak of
0 Comments
Researchers have warned that the United States has not yet reached the necessary thresholds for achieving population immunity against severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). The team – from RTI International in Research Triangle Park, North Carolina, and Pfizer Inc. in Collegeville, Pennsylvania – says that
0 Comments
In this article PFE Lisa Wilson receives a shot of the Pfizer vaccine at a mobile COVID-19 vaccination site in Orlando, Florida. Paul Hennessy | SOPA Images | LightRocket | Getty Images A key Centers for Disease Control and Prevention advisory group voted Thursday to recommend distributing Pfizer and BioNTech‘s Covid-19 booster shots to older Americans, nursing
0 Comments
Outbreaks of infectious diseases have been recorded throughout history. Currently, SARS-CoV-2, a contagious virus that causes the disease called COVID-19, is impacting individuals worldwide. Many countries have set their sight on an effective vaccination program to end their infectious disease outbreaks. The term “herd immunity” has been mentioned in association with ending the COVID-19 outbreaks.
0 Comments
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 23, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order. “I want to thank Health
0 Comments
Now that the first COVID-19 vaccines are being rolled out, Operation Warp Speed, the FDA, and the CDC have recommended that governors proceed first with vaccinating two groups: healthcare workers and residents in nursing homes. But what about after that? Planning has started in all the states and territories regarding who will get the vaccine
0 Comments
National Institutes of Health Director Dr. Francis Collins told CNBC that “it was very likely” that the U.S. government is close to a deal with Pfizer for up to an additional 100 million Covid vaccine doses.  “It is good news it sounds like it’s very likely,” said Collins. “We’ll have 400 million doses between Pfizer
0 Comments
NEW YORK and MAINZ, GERMANY, December 12, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older under the Emergency Use Authorization
0 Comments
Print this page PLYMOUTH MEETING, Pa., Sept. 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it has additional questions about the company’s
0 Comments